We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Agilent (A) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Read MoreHide Full Article
In its upcoming report, Agilent Technologies (A - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.72 per share, reflecting an increase of 8.2% compared to the same period last year. Revenues are forecasted to be $1.98 billion, representing a year-over-year increase of 6.7%.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.8% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Agilent metrics that are commonly tracked and forecasted by Wall Street analysts.
It is projected by analysts that the 'Net Revenue- Applied Markets' will reach $373.20 million. The estimate suggests a change of +6.3% year over year.
The collective assessment of analysts points to an estimated 'Net Revenue- Agilent Crosslab' of $800.08 million. The estimate indicates a change of +6% from the prior-year quarter.
Analysts forecast 'Net Revenue- Life Sciences and Diagnostics Markets' to reach $810.50 million. The estimate indicates a year-over-year change of +7.4%.
Over the past month, Agilent shares have recorded returns of -0.5% versus the Zacks S&P 500 composite's -4% change. Based on its Zacks Rank #3 (Hold), A will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Image: Bigstock
Agilent (A) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
In its upcoming report, Agilent Technologies (A - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.72 per share, reflecting an increase of 8.2% compared to the same period last year. Revenues are forecasted to be $1.98 billion, representing a year-over-year increase of 6.7%.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.8% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Agilent metrics that are commonly tracked and forecasted by Wall Street analysts.
It is projected by analysts that the 'Net Revenue- Applied Markets' will reach $373.20 million. The estimate suggests a change of +6.3% year over year.
The collective assessment of analysts points to an estimated 'Net Revenue- Agilent Crosslab' of $800.08 million. The estimate indicates a change of +6% from the prior-year quarter.
Analysts forecast 'Net Revenue- Life Sciences and Diagnostics Markets' to reach $810.50 million. The estimate indicates a year-over-year change of +7.4%.
View all Key Company Metrics for Agilent here>>>Over the past month, Agilent shares have recorded returns of -0.5% versus the Zacks S&P 500 composite's -4% change. Based on its Zacks Rank #3 (Hold), A will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .